Plain-English translation of NCT05939063 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer surgical technique called laparoscopic radical antegrade modular pancreatosplenectomy (LRAMPS) works as well as the standard surgery, laparoscopic distal pancreatosplecnectomy (LDP), for treating early-stage pancreatic cancer located on the left side of the pancreas. Both are minimally invasive 'keyhole' surgeries, but they differ in how much tissue is removed and the order in which the surgeon works. The study wants to see if the newer technique offers better results without increasing risks.
While the newer surgical technique shows promise for larger tumors, it hasn't been thoroughly studied in patients with smaller, early-stage cancers. This trial exists to determine whether this approach is safe and effective specifically for early-stage tumors, and whether it might offer advantages over the standard surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to receive one of the two surgical techniques—either LRAMPS or standard LDP. Both are performed using laparoscopic (minimally invasive) methods, meaning the surgeon uses small cuts and a camera instead of one large incision. You will have the surgery as your treatment, and the research team will then follow you to track how well you recover, how long surgery takes, complication rates, and your long-term cancer outcomes. The study will compare how the two surgical approaches perform in these areas.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China